US Material Events SEC 8-K Filings — July 13, 2026

13-07-2026

Franklin Street Properties Corp. completed the sale of a property in Englewood, Colorado for $19.4 million on July 8, 2026. The transaction generated net proceeds of $17.5 million, of which $8.5 million was used to partially repay borrowings, resulting in a $1.1 million loss on debt extinguishment. Pro forma results show the disposition reduces rental revenue and expenses but does not materially change the company's net loss position, with pro forma net loss per share remaining at $(0.09) for Q1 2026 and widening to $(0.51) for FY 2025 (from $(0.43) historical).

• · The sale was completed on July 8, 2026, pursuant to a Purchase and Sale Agreement dated May 26, 2026, as amended on June 30, 2026.
• · No material relationships existed between the Seller and Buyer or their affiliates other than the Agreement.
• · Pro forma total assets decrease from $881.8M to $864.9M, and total liabilities decrease from $285.4M to $277.4M.
• · Pro forma rental revenue for FY 2025 declines by $4.2M to $103.0M, and for Q1 2026 declines by $1.1M to $25.2M.
• · Pro forma net loss for FY 2025 worsens from $(45.0M) historical to $(52.7M) pro forma, primarily due to the nonrecurring loss on sale of $7.9M.
• · The company remains a qualified REIT with no federal income tax provision on real estate operations.

13-07-2026

On July 9, 2026, Edward M. Weil, Jr. resigned as a Class III director and Chairman of the Board of American Strategic Investment Co. for personal reasons, with no disagreement with the company. The following day, the Board appointed Nicholas S. Schorsch, Jr., the company's CEO since March 2025, as a Class III director and Chairman to fill the vacancy. Schorsch, Jr. brings extensive real estate and financial services experience, having helped source over $1 billion in real estate acquisitions and participated in over $20 billion of corporate M&A transactions.

• · Schorsch, Jr. has served as CEO of the company since March 2025.
• · He is the son of Nicholas S. Schorsch.
• · He has been COO of AR Global Investments, LLC since 2015.
• · He previously served as President of G&P Acquisition Corp from 2020 to 2022.
• · He is a graduate of Sarah Lawrence College with a Bachelor of Arts degree.
• · No family relationships exist between Schorsch, Jr. and any other director or executive officer.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist between Schorsch, Jr. and the company.

13-07-2026

Amphastar Pharmaceuticals appointed Anthony Pierce as a Class III director, effective July 9, 2026, increasing the board size from 10 to 11. Mr. Pierce is independent under Nasdaq standards and will receive an annual cash retainer of $55,000 (pro-rated) and an initial equity grant with an aggregate grant date fair value of $300,000, consisting of 50% restricted stock units and 50% stock options. No other financial metrics or period-over-period comparisons are provided in this filing.

• · Mr. Pierce was not appointed to any board committees at this time.
• · The board size was increased from 10 to 11 directors.
• · Mr. Pierce's initial equity grant vests on the first anniversary of the grant date, subject to continued service.
• · The company will enter into its standard form of indemnification agreement with Mr. Pierce.

13-07-2026

Public Storage (PSA) and its subsidiary PSOC entered into an underwriting agreement on July 9, 2026, to sell $900 million aggregate principal amount of senior notes in two tranches: $400 million of 4.700% notes due 2032 and $500 million of 5.150% notes due 2036. The net proceeds will partially finance the pending acquisition of National Storage Affiliates Trust and for general corporate purposes. The offering is expected to close on July 20, 2026.

• · The 2032 notes were issued at 99.283% of par value and mature on February 1, 2032.
• · Interest on the 2032 notes is payable semi-annually on February 1 and August 1, commencing February 1, 2027.
• · The 2036 notes were issued at 98.553% of par value and mature on August 15, 2036.
• · Interest on the 2036 notes is payable semi-annually on February 15 and August 15, commencing February 15, 2027.
• · The offering was made under a shelf registration statement on Form S-3 filed December 2, 2024.
• · The underwriting agreement includes customary representations, warranties, and indemnification provisions.

13-07-2026

Silo Pharma, Inc. announced a private placement of up to $11.7 million, with $4 million in upfront gross proceeds and up to $7.7 million in potential additional proceeds from the exercise of warrants. The offering, priced at-the-market under Nasdaq rules, involves the sale of common stock and warrants at $6.452 per share, with H.C. Wainwright & Co. acting as exclusive placement agent. However, there is no assurance that any warrants will be exercised, and the company remains a developmental-stage biopharmaceutical firm with no approved products, highlighting significant execution risk.

• · The offering is a private placement under Section 4(a)(2) of the Securities Act and Regulation D, and the securities are not registered under the Act.
• · Silo Pharma has agreed to file a Resale Registration Statement with the SEC to cover the resale of the unregistered securities.
• · The Series A-3 warrants expire five years after the effective date of the Resale Registration Statement; the Series A-4 warrants expire eighteen months after that date.
• · The company intends to use net proceeds for working capital and general corporate purposes.
• · Silo Pharma is a developmental-stage biopharmaceutical company with no approved products, focusing on stress-induced psychiatric disorders, chronic pain, and CNS diseases.

13-07-2026

Compass Diversified (CODI) announced amendments to its Management Services Agreement that will reduce base management fees from 2.00% to 1.25% of Adjusted Net Assets (ANA) effective January 1, 2027, with a $30 million cap on 2027 base fees. The new structure replaces the existing incentive fee with a Share Alignment Award (0.125% of average ANA) and a Performance-Based Award (0.125% of average ANA) tied 70% to relative TSR and 30% to EBITDA, including a provision that the TSR component pays nothing if CODI's share price plus distributions does not reach at least $17.25 by end of 2027. Total 2027 management fees are expected to decline by approximately $19 million to $22 million compared to the prior formula. The company reaffirmed its full-year 2026 outlook, noting subsidiaries continue to perform well.

• · The Amended MSA follows a Board-led review that considered investor perspectives, market practices and pre-existing contractual requirements.
• · The Performance-Based Award's TSR component pays nothing if CODI's total shareholder return is negative, and for 2027 pays nothing unless CODI's share price plus distributions reaches at least $17.25 at end of 2027.
• · CODI and the Manager intend to seek shareholder approval at CODI's 2027 annual meeting for an equity-based incentive structure to replace the cash-based awards beginning in 2028.
• · The Amended MSA includes clawback and recoupment provisions and Compensation Committee oversight.
• · CODI reaffirmed its previously issued full-year 2026 outlook.

13-07-2026

Agenus announced an oversubscribed private placement of up to $340 million, with $85 million in upfront gross proceeds and up to $255 million upon exercise of warrants, led by Commodore Capital. The funds will advance the registrational ROBBIN Phase 3 trial of neoadjuvant BOT+BAL in MSS colon cancer, targeting a >$7 billion annual US market. However, the company is discontinuing financial support for the ongoing BATTMAN Phase 3 study in late-line metastatic MSS CRC, and the financing includes dilution risk from warrant exercises.

• · Private placement priced at a premium to market closing price as of July 10, 2026.
• · Series A warrants expire on the earlier of 5 years or 30 days after public disclosure of 60 patients dosed in ROBBIN.
• · Series B warrants expire on the earlier of 5 years, 30 days after pathologic response data for 50 patients in ROBBIN, or immediately after Series A expiration if not fully exercised.
• · Agenus will increase board size to nine directors, with two designated by Commodore Capital.
• · ROBBIN trial first patient dosed anticipated Q1 2027; interim pathologic response data H2 2027; interim EFS analysis H2 2029; final EFS analysis H2 2030.
• · No new curative-intent therapies approved for MSS colon cancer in over 20 years.
• · All treated patients in NEST/UNICORN remained disease free with median follow-up of 9-18 months.
• · Agenus will honor obligations to patients in BATTMAN study and work with CCTG to manage transition.

13-07-2026

Future Vision II Acquisition Corp. (FVNNR) issued a $191,475 unsecured promissory note to HWei Super Speed Co. Ltd. to fund a one-month extension of its deadline to complete a business combination, from July 13, 2026 to August 13, 2026. The note carries no interest and is convertible into units at $10.00 per unit upon a business combination, but is forgiven if no deal closes. This extension loan signals the SPAC is still pursuing a merger but has not yet consummated a business combination, and the note's conversion feature is capped at $1,500,000 aggregate.

• · The note is unsecured, bears no interest, and is payable upon consummation of a business combination.
• · Proceeds must be deposited into the trust account to extend the business combination deadline from July 13, 2026 to August 13, 2026.
• · The note can be converted into units at $10.00 per unit, identical to placement units from the IPO private placement.
• · Conversion is capped at an aggregate $1,500,000 across all similar working capital/extension loans from the Payee and affiliates.
• · If no business combination occurs by the extended deadline, the note is forgiven and the Payee has no right to payment.
• · The Payee waives any claim to the trust account distributions.
• · The note is governed by New York law and cannot be assigned without Maker's consent prior to a business combination.

13-07-2026

Brand Engagement Network Inc. (BNAIW) entered into a new employment agreement with CEO Tyler Luck on June 28, 2026, effective June 1, 2026 through June 1, 2029. The agreement provides a base salary of $360,000, one-time payments totaling $275,000 for prior services, a non-qualified option for 100,000 shares, and performance-based compensation tied to Russell 1000 Growth Index listing, patent licensing revenue, and market capitalization thresholds of $1.0B, $2.0B, and $3.0B. The company may only terminate for Good Cause and must pay base salary for the longer of the remaining term or one year.

• · CEO Tyler Luck has served as CEO since September 14, 2025, previously as Chief Product Officer.
• · The employment agreement includes non-disclosure and IP assignment covenants.
• · Company is an emerging growth company and has not elected the extended transition period for new accounting standards.
• · The agreement was filed as Exhibit 10.1 to the 8-K.

13-07-2026

Plug Power announced two asset monetization transactions with Stream Data Centers expected to deliver over $80 million in near-term liquidity as part of a broader initiative targeting more than $275 million in liquidity improvement. The company sold its Graham, Texas project for up to $76.5 million and restructured the New York Gateway project sale with a fixed price of $142 million, while also exploring further opportunities in the data center industry. However, the company held only $162 million in unrestricted cash as of June 30, 2026, and the New York closing is subject to extended regulatory reviews with a long-stop date of March 31, 2027.

• · The Graham, Texas project includes 164 MW of grid interconnection assets.
• · The New York Gateway project long-stop closing date for non-land assets is extended to March 31, 2027.
• · Plug will retain ownership of the substation and interconnection assets at the Gateway site until the second closing.
• · Plug has deployed more than 74,000 fuel cell systems and over 280 fueling stations globally.
• · Plug's hydrogen plants in Georgia, Tennessee, and Louisiana can produce up to 40 tons per day.
• · Plug employs more than 730 people in New York and nearly 200 in Texas.
• · Plug's fuel cell forklifts have helped customers avoid nearly 95,000 MWh of annual electricity consumption and prevent more than 33,000 metric tons of CO2 emissions each year.

13-07-2026

N-able, Inc. announced the departure of Chief Revenue Officer Frank Colletti, effective July 9, 2026, and the immediate appointment of Russell Rosa as his replacement. Colletti may be entitled to severance under his existing agreement, with any material modifications to be disclosed later. The change is effective as of July 9, 2026, and includes no financial or operational performance metrics.

• · Russell Rosa will oversee N-able's global sales organization, channel and partner ecosystem, support, and sales operations.
• · Colletti's severance is subject to terms of his previously disclosed employment agreement.

13-07-2026

On July 8, 2026, CEVA, Inc. announced the mutual resignation of Michael Boukaya, Executive Vice President and Chief Operating Officer, effective August 1, 2026. He will remain an employee through December 31, 2026 to ensure a smooth transition. The filing does not disclose a successor or any financial impact.

• · Mr. Boukaya's last day as COO is August 1, 2026, and he will remain an employee until December 31, 2026 for transition purposes.
• · No successor or interim COO has been announced in this filing.

13-07-2026

Singularity Future Technology Ltd. entered into a securities purchase agreement on July 6, 2026, and closed the offering on July 13, 2026, selling 5,263,158 units at $0.38 per unit for aggregate gross proceeds of approximately $2,000,000. Each unit consists of one share of common stock and three warrants exercisable at $0.418 per share, expiring in five years. The offering was conducted as a private placement to non-U.S. persons under Regulation S, with the shares and warrants issued accordingly.

• · The warrants are exercisable immediately upon issuance at $0.418 per share, for cash, and may be exercised cashlessly if no effective registration statement or current prospectus is available after one month from issuance.
• · The warrants expire five years from the date of issuance and are subject to customary anti-dilution provisions.
• · The offering was conducted under the exemption from registration provided by Regulation S of the Securities Act of 1933.
• · The securities purchase agreement includes customary representations, warranties, and covenants, including that purchasers are non-U.S. persons acquiring shares for investment purposes.

13-07-2026

Revelation Biosciences adopted a stockholder rights plan (poison pill) to protect against hostile takeovers, triggering at 10% ownership (15% for passive institutional investors). The plan is a standard governance measure that does not affect financial condition or operations, and expires in one year unless stockholder approval extends it to three years.

• · Dividend distribution of one Right per outstanding share of common stock payable to stockholders of record as of July 21, 2026.
• · Rights will trade with common stock until exercisable and are not separately transferable.
• · Rights expire on first anniversary of adoption (July 10, 2027) unless stockholders approve, extending to third anniversary.
• · Company is a clinical-stage life sciences company focused on rebalancing inflammation using Gemini formulation.
• · Ongoing programs: acute kidney injury, chronic kidney disease, prevention of post-surgical infection, and treatment for hyperinflammation/infection from severe burns.

13-07-2026

MSP Recovery, Inc. has entered into a letter agreement with Virage Capital Management LP for a one-time limited advance of $250,000 to support ongoing operational expenses, amid the company's non-performance under existing transaction documents. The advance is conditioned on strict use of proceeds (including $75,000 for legal fees to Cole Schotz P.C.), directing opioid and other recovery proceeds to a Virage-controlled account, and amending the security agreement to remove the operating reserve from excluded property. This marks the latest in a series of prior consents and cash advances since September 2025, highlighting the company's continued financial distress and reliance on Virage for liquidity.

• · The advance is conditioned on directing opioid and other recovery proceeds to a Virage-controlled account (Bank of America) by August 1, 2026.
• · Virage will act as agent for third-party lienholders (including Hazel) to perfect liens via control over the collection account.
• · The MTA and Security Agreement are amended to remove the 'Operating Reserve' and 'Reserve Account' from Excluded Property, expanding VRM's collateral.
• · The MSP Companies must deliver all claims data subject to VRM's security interests to Virage or its authorized custodian.
• · The letter agreement is governed by New York law and is not a novation of existing obligations.

13-07-2026

On July 7, 2026, Raymond S. Frech resigned as CFO of American Shared Hospital Services for personal reasons, effective immediately, with no disagreement over accounting policies. The board appointed Alexis N. Tirrito (Wallace), the company's CAO and Secretary, as interim CFO, with a base salary of $240,000 and a 20% target bonus. The change is orderly and non-contentious, with no negative financial impact reported.

• · Raymond S. Frech resigned as CFO on July 7, 2026, effective immediately, for personal reasons with no disagreement over accounting policies.
• · Alexis N. Tirrito, age 42, has been with the company since April 2013 and served as CAO and Secretary since October 2021.
• · Ms. Tirrito's base salary as interim CFO is $240,000, with a target bonus of 20% of base salary.
• · The company entered into a customary severance agreement with Mr. Frech including general releases and waivers.

13-07-2026

Phoenix Education Partners, Inc. appointed Robert Brackenbury to its Board of Directors as a Class I director and audit committee member, effective July 9, 2026. Mr. Brackenbury brings extensive experience from the State of Michigan Retirement System, where he oversaw over $170 billion in assets, and from senior roles at Eastern Michigan University. The filing contains no financial results or period-over-period comparisons.

• · Mr. Brackenbury served as Deputy Chief Investment Officer at the State of Michigan Retirement System from 2010 to 2026.
• · He holds a J.D. from Wayne State University Law School and an MBA from the University of Michigan Ross School of Business.
• · He completed the Senior Executives in State and Local Government Program at Harvard Kennedy School.
• · He currently serves on the board of Athene Holding Ltd.
• · He will receive director compensation as described in the Company's 2025 Proxy Statement.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.

13-07-2026

ONE Gas, Inc. appointed Nickolas Stavropoulos to its board of directors, effective July 13, 2026, expanding the board from eight to nine members. Stavropoulos brings over 40 years of energy industry experience, including roles as COO of PG&E and National Grid, and deep expertise in safety, operations, and regulatory affairs.

• · Stavropoulos holds a BS in accounting from Bentley University and an MBA from Babson College, with executive certificates from Harvard and MIT.
• · He currently serves on the board of Ameresco (NYSE: AMRC).
• · ONE Gas is a 100% regulated natural gas utility, part of the S&P MidCap 400, serving over 2.3 million customers across Kansas, Oklahoma, and Texas.

13-07-2026

Realty Income Corporation announced the recast and expansion of its revolving credit facilities to $5.5 billion (from $4.0 billion) and its commercial paper programs to $5.5 billion (from $3.0 billion). The new facilities feature improved pricing (80 bps over SOFR, down 5 bps) and extended maturities through 2029/2030, strengthening the company's liquidity and financial flexibility. No negative or flat metrics were reported in this filing.

• · The revolving credit facilities are bifurcated into two $2.75 billion tranches with initial maturities on April 29, 2029 and July 10, 2030, each with two six-month extension options.
• · Borrowing rate is 67.5 bps over SOFR for USD borrowings, with a facility commitment fee of 12.5 bps, resulting in all-in drawn pricing of 80 bps over SOFR.
• · The company's current credit ratings are A3 / A-.
• · Commercial paper notes will rank pari passu with all other unsecured senior indebtedness.
• · The revolving credit facilities serve as a liquidity backstop for commercial paper repayments.
• · Realty Income has declared 673 consecutive monthly dividends and has increased its dividend for over 31 consecutive years.

13-07-2026

Tarsus Pharmaceuticals announced that Chief Commercial Officer Aziz Mottiwala will depart on July 15, 2026, to become CEO of a public medical device company. The departure is a key leadership change, but no financial impact or replacement details were disclosed.

• · Aziz Mottiwala's last day of employment is July 15, 2026.
• · He is leaving to become CEO of a public medical device company.
• · No successor or interim plan for the Chief Commercial Officer role was announced.

13-07-2026

Accel Entertainment's Compensation Committee approved the 2026 Long Term Incentive Program awards and the 2026 Short Term Incentive Program on July 11, 2026. The 2026 LTI Awards consist of 50% time-based RSUs and 50% performance-based PSUs (with default 30% relative TSR and 70% stock price goals), with grants to named executive officers including Mark Phelan (CEO-elect), Scott Levin, and Brett Summerer. The 2026 STI Program sets annual cash bonus targets based 80% on financial metrics and 20% on individual performance goals.

13-07-2026

SHF Holdings, Inc. announced the resignation of Douglas Beck, Principal Accounting Officer and Senior Vice President of Finance, Controller, effective July 31, 2026. The departure is not due to any disagreement with the company regarding operations, policies, or practices. The company has not yet disclosed a successor or interim arrangement.

• · Resignation effective July 31, 2026.
• · No disagreement with the company cited as reason for departure.
• · No successor or interim appointment announced.

13-07-2026

Pliant Therapeutics expanded its Board from seven to nine members, appointing Dr. Robert Iannone as a Class I director and Dr. Flavia Borellini as a Class II director, effective July 9, 2026. Dr. Iannone will serve on the R&D Committee, and Dr. Borellini will chair it. Both are independent directors, and each received an option to purchase 60,000 shares vesting over three years, along with annual retainers ($40,000 each, plus committee fees). No financial results or period-over-period comparisons are included in this filing.

• · Board size increased from 7 to 9 members.
• · Dr. Iannone and Dr. Borellini are independent directors with no reportable transactions under Item 404(a).
• · Each director received a standard indemnification agreement.
• · The stock options vest in equal monthly installments over three years, subject to continuous service.

13-07-2026

NXG Cushing Midstream Energy Fund filed an 8-K on July 13, 2026, reporting entry into a material definitive agreement (Item 1.01) and other events (Item 8.01). The filing contains no financial results, no period-over-period comparisons, and no quantitative data beyond the fact of the agreement itself.

• · Filing type: 8-K, dated July 13, 2026
• · Items reported: 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), 9.01 (Financial Statements and Exhibits)
• · No financial figures, percentages, or period comparisons are disclosed in the filing

13-07-2026

Galaxy Digital Inc. appointed Steven Bandrowczak, 65, to its Board of Directors effective July 13, 2026, with his initial term expiring at the 2027 annual meeting. Mr. Bandrowczak, former CEO of Xerox Holdings Corporation (2022-2026), will also serve on the audit committee. The appointment is a routine board refreshment with no disclosed material transactions or arrangements.

• · Steven Bandrowczak, 65, appointed to the Board effective July 13, 2026, with term expiring at the 2027 annual meeting.
• · He will serve on the audit committee.
• · Bandrowczak was CEO of Xerox Holdings Corporation from August 2022 to March 2026.
• · He holds a B.S. in Computer Science from Long Island University and an M.S. in Technology Management from Columbia University.
• · He will participate in the non-employee director compensation program and enter into a standard indemnification agreement.

13-07-2026

Energy Recovery, Inc. (ERII) announced the appointment of John Mitchell to its Board of Directors, effective July 13, 2026. Mr. Mitchell brings over 30 years of global leadership experience in finance, operations, and technology-intensive industrial businesses, most recently as SVP and GM of Sensor Solutions at TE Connectivity. The filing contains no financial results or period-over-period comparisons.

• · Mr. Mitchell holds an MBA in Finance and General Management from University College Dublin and a Bachelor of Business Studies in Finance from the University of Limerick.
• · He previously served as President of TE SubCom, an undersea communications technology and marine services pioneer.
• · Energy Recovery is headquartered in San Leandro, California, with manufacturing and R&D facilities throughout California and global sales and technical support.

13-07-2026

Sunbelt Rentals Holdings, Inc. announced the appointment of Ekta Singh-Bushell to its Board of Directors as a non-executive director, effective August 1, 2026. Ms. Singh-Bushell brings extensive experience in finance, audit, technology, and cybersecurity, having served on the boards of ChargePoint, Lesaka Technologies, and previously Cisco, TTEC Holdings, Designer Brands, and Datatec. The company operates with 26,000 employees, over 1,600 locations, and a fleet of assets exceeding $19 billion.

• · Ms. Singh-Bushell holds an M.S. in electrical engineering and computer science from UC Berkeley and a bachelor's degree in engineering from the University of Poona.
• · She is a certified public accountant, a National Association of Corporate Directors fellow, and holds advanced international certifications in governance, sustainability, information systems security, audit and control.
• · Most recently, she served as COO of Dragos Inc., a privately held global cybersecurity company.
• · Previously, she held leadership positions at the Federal Reserve Bank of New York and Ernst & Young, including chief information security officer.

13-07-2026

CO2 Energy Transition Corp. (NOEMR) entered into a convertible promissory note with its sponsor, CO2 Energy Transition, LLC, for up to $229,700 to fund the first of six possible one-month extensions to complete a business combination. The note is non-interest bearing, matures upon the earlier of a business combination or winding up, and is convertible into private placement units at $10.00 per unit upon a successful business combination. However, if no business combination is consummated, repayment is limited to funds available outside the trust account, and the payee has waived any claim against the trust account, highlighting significant downside risk for the sponsor.

• · The note is non-interest bearing with no prepayment allowed without payee consent.
• · Conversion option is available only upon consummation of a business combination, with at least five business days' notice required.
• · The payee has waived all claims against the trust account, meaning repayment is limited to funds outside the trust if no deal closes.
• · The note is governed by New York law and includes standard events of default for non-payment and bankruptcy.

13-07-2026

Splash Beverage Group, Inc. entered into a letter agreement with Decathlon Alpha IV, L.P. to settle outstanding obligations of $2,834,689 under a Revenue Loan and Security Agreement for a discounted payment of $301,800.55 by August 31, 2026. Upon receipt, the lender will irrevocably release the company from all obligations under the loan. This settlement significantly reduces the company's debt burden but reflects a distressed financial situation.

• · The original Loan Agreement was dated December 24, 2020, and previously disclosed in an 8-K filed on December 31, 2020.
• · The settlement payment is due on or before August 31, 2026.
• · The release is described as 'forever irrevocably and unconditionally' covering all claims, charges, demands, fees, liabilities, obligations, indebtedness, damages, costs, and expenses.

13-07-2026

Intapp, Inc. entered into a new $150.0 million senior secured revolving credit facility on July 7, 2026, replacing its prior credit agreement. The new facility matures in five years and includes an accordion feature allowing up to $75.0 million in additional commitments. No amounts were drawn at closing, and proceeds are intended for working capital, general corporate purposes, and acquisitions.

• · The credit facility is secured by a first priority pledge of capital stock of first-tier subsidiaries and substantially all assets (excluding real estate).
• · The facility includes a maximum consolidated total net leverage ratio covenant.
• · The prior credit agreement with JPMorgan Chase Bank, N.A. was terminated concurrently with the new agreement.
• · Interest rates are based on Term SOFR plus 1.50%-2.25% or an alternate base rate plus 0.50%-1.25%, depending on the company's total net leverage ratio.
• · Commitment fees on unused amounts range from 0.25% to 0.40% annually.

13-07-2026

Chicago Atlantic Real Estate Finance, Inc. (REFI) completed a $62.5M second-lien financing of 32 cannabis retail properties managed by Koach Properties Manager LLC, issuing 4,306,754 common shares at $14.53 per share. The notes carry a 10.0% cash interest rate plus 2.0% PIK interest and a 12-year weighted average maturity. The transaction provides REFI with exposure to a portfolio of retail properties leased to leading cannabis operators, but the press release also notes a pending merger with Chicago Atlantic BDC, Inc. (LIEN) that introduces execution risk and potential dilution for shareholders.

• · The notes have an aggregate weighted average time to maturity of approximately 12 years.
• · The notes provide for an exit fee of 2.5 times the commitment amount of each note.
• · The notes are secured on a second-lien basis by retail properties leased to a portfolio of leading cannabis operators.
• · REFI expects to benefit from Koach's strategy of acquiring, stabilizing, and opportunistically disposing of retail properties.
• · The press release also references a pending merger of REFI with Chicago Atlantic BDC, Inc. (LIEN) pursuant to a June 17, 2026 Merger Agreement.

13-07-2026

Arhaus, Inc. announced the resignation of Bill Beargie from its Board of Directors on July 7, 2026, which was not due to any disagreement with the company. The Board appointed Rick Keyes, President and CEO of Meijer, Inc., as an independent director effective July 8, 2026, to serve on the Compensation Committee with a term expiring at the 2028 Annual Meeting. No financial metrics or period-over-period comparisons are included in this filing.

• · Rick Keyes has served as President and CEO of Meijer, Inc. since 2017 and held various leadership roles at Meijer since 1989.
• · Keyes currently serves as a director of CMS Energy Corporation and its subsidiary Consumers Energy Company, on its Audit and Governance, Sustainability and Public Responsibility committees.
• · Keyes is Chair of the Board of Trustees of Ohio Northern University.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist between Keyes and the company.
• · Keyes's compensation will be consistent with other non-employee directors as described in the 2026 proxy statement.

13-07-2026

Oil States International, Inc. amended the Executive Agreement of President and CEO Lloyd A. Hajdik on July 9, 2026, restructuring severance benefits upon qualifying termination events. Under the amendment, Mr. Hajdik would receive a lump sum severance equal to 3.0 times the sum of his Termination Base Salary and Target AICP if terminated without Cause or resigns for Good Reason within 24 months following a Change of Control, or 1.5 times that sum if terminated without Cause outside that period. All other terms of the Executive Agreement remain unchanged.

• · The amendment was effective July 9, 2026.
• · Severance multiplier is 3.0x within 24 months post-Change of Control, and 1.5x outside that period.
• · The original Executive Agreement was effective December 9, 2013.
• · The amendment is filed as Exhibit 10.1 to the Form 8-K.

13-07-2026

MBX Biosciences announced the departure of CEO Kent P. Hawryluk effective July 13, 2026, with a separation agreement including 12 months' salary, bonus, and equity vesting. The company appointed Steven Hoerter, formerly executive Chairman, as President and CEO with a $665,000 base salary and equity grants, and John Smither as permanent CFO with a $530,000 base salary and a $150,000 relocation bonus. The leadership changes are orderly and not due to any dispute.

• · Kent Hawryluk's departure is not due to any dispute or disagreement with the company or auditors.
• · Hawryluk will provide strategic advisory services through August 16, 2026 under a consulting agreement.
• · Hawryluk's severance includes 12 months' base salary, COBRA coverage, target annual bonus, and accelerated vesting of time-based equity through August 16, 2027.
• · Hawryluk's post-termination stock option exercise period is extended to July 13, 2027.
• · Steven Hoerter's equity awards vest over 4 years: options with 1-year cliff and 36-month monthly vesting, RSUs with 25% annual vesting.
• · John Smither's equity awards have the same vesting schedule as Hoerter's.
• · Smither's relocation bonus is paid in two installments: 50% within 30 days of effective date and 50% by January 15, 2027.

13-07-2026

Brown-Forman announced that President & CEO Lawson Whiting will retire upon the appointment of a successor. The Board has initiated a search considering internal and external candidates, led by the Corporate Governance and Nominating Committee. The company reiterated its fiscal 2027 outlook, and the transition is described as occurring from a position of strength, with no negative financial metrics reported.

• · Whiting will remain in an advisory capacity after the successor is appointed to ensure business continuity.
• · Under Whiting's leadership, Old Forester tripled in volume and increased net sales six-fold over the last decade.
• · Wolf Pen Branch, representing a controlling interest, expressed confidence in the Board's succession process.
• · The company reiterated its fiscal 2027 outlook as disclosed on June 4, 2026.

13-07-2026

On July 13, 2026, Federal Home Loan Bank of Indianapolis announced that Board Chair Robert M. Fisher will not stand for reelection in the 2027 director election, citing personal reasons. He will continue to serve until his term expires on December 31, 2026. The departure is not due to any disagreement with the Bank.

• · Mr. Fisher's current term expires on December 31, 2026.
• · The decision is based solely on personal reasons and not due to any disagreement with the Bank.

13-07-2026

CoStar Group (CSGP) announced the appointment of Robin Rossmann as CFO, effective July 31, 2026, succeeding Christian Lown, who is leaving for an opportunity outside the industry. Rossmann, currently Managing Director, Europe, has reduced the European cost structure by 25% (approximately $51 million) over the past two years while delivering double-digit revenue growth and launching CoStar in France. The outgoing CFO's departure was not due to any disagreement with the company.

• · Rossmann joined STR in 2016 and became part of CoStar Group through the 2019 acquisition of STR.
• · Prior to STR, Rossmann spent 13 years at Deloitte as a Senior Director advising real estate and hospitality companies.
• · Rossmann is a Chartered Accountant.
• · Lown's departure was not due to any disagreement with the company regarding operations, policies, or practices.
• · CoStar Group's websites attracted 131 million average monthly unique visitors in Q1 2026.

13-07-2026

Healthy Extracts Inc. announced the resignation of Aaron Hefter as Chief Brand Officer, effective July 7, 2026. The position will remain vacant until further notice. This is a routine officer departure with no financial impact disclosed.

• · The resignation was effective July 7, 2026.
• · The filing was made on July 13, 2026.
• · No replacement has been named; the position remains vacant.

13-07-2026

Workhorse Group Inc. announced the departure of CFO Robert M. Ginnan effective July 13, 2026, with employment ending July 17, 2026, and appointed Jody Davis as new CFO and Lindsay A. Barnes as Chief Accounting Officer. Davis receives a $375,000 base salary, 93,750 RSUs, and 50% target bonus. The changes follow the acquisition of Motiv Power Systems.

• · Robert Ginnan's employment terminates on July 17, 2026.
• · Jody Davis previously served as VP, Strategic Finance at Unimacts Global from March 2026.
• · Lindsay Barnes has been with Workhorse as VP, Corporate Controller since November 2025.
• · Davis's RSUs vest in three equal annual installments starting one year from grant date.
• · No change to Barnes' compensation as a result of her appointment.

13-07-2026

Aptera Motors Corp. (NASDAQ: SEV) announced the closing of a warrant inducement transaction, generating approximately $5.96 million in gross proceeds through the immediate exercise of warrants for 2,880,000 shares of Class B Common Stock at a reduced price of $2.07 per share. In exchange, the company issued new warrants to purchase up to 4,320,000 shares at $2.25 per share, exercisable after six months and expiring in five and a half years. The net proceeds will be used for working capital, general corporate purposes, and continued advancement of validation vehicle manufacturing and testing.

• · The warrants exercised were originally issued in March 2026.
• · The new warrants have an exercise price of $2.25 per share, are exercisable beginning six months after issuance, and expire five and a half years from issuance.
• · A.G.P./Alliance Global Partners acted as exclusive financial advisor.
• · The company has agreed to file a registration statement with the SEC covering the resale of shares issuable upon exercise of the new warrants.
• · The offering was conducted as a private placement under Section 4(a)(2) of the Securities Act and/or Regulation D.

13-07-2026

Streamex Corp. dismissed CBIZ CPAs as its independent auditor on July 8, 2026, and appointed EisnerAmper LLP as its new auditor, effective the same date. The change was approved by the Audit Committee and is not due to any disagreement with CBIZ CPAs. However, the filing discloses that during CBIZ CPAs' tenure, there were material weaknesses in internal control over financial reporting, including inadequate identification of stock-based compensation, ineffective review processes, segregation of duties, and controls over business combinations.

• · The material weaknesses in internal control over financial reporting were initially reported in Item 9A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed on March 31, 2026.
• · The material weaknesses include: (i) inadequate identification, recording and reporting of stock-based compensation; (ii) ineffective review processes over period-end financial disclosure and reporting, including review of IPE; (iii) inadequate segregation of duties for transaction posting and processing; and (iv) ineffective review controls over business combinations and related financial instruments.
• · CBIZ CPAs was originally appointed on April 30, 2025, following the resignation of Marcum LLP due to CBIZ CPAs' acquisition of Marcum's attest business.
• · The report of CBIZ CPAs on the financial statements for the fiscal year ended December 31, 2025, did not contain an adverse opinion or disclaimer of opinion, nor was it qualified or modified.

13-07-2026

Talos Energy Inc. issued $800M of 8.000% Second-Priority Senior Secured Notes due 2034 to partially fund its pending Gulf of America acquisition of oil and gas properties (including Na Kika and Coulomb assets) and to redeem all of its outstanding 9.000% Notes due 2029. The notes carry an 8% coupon, mature July 15, 2034, and include a special mandatory redemption provision of $175M if the acquisition fails to close by December 31, 2026 or if BP exercises a preferential right. The company simultaneously redeemed its higher-cost 9.000% notes at 104.5% of par, reducing its interest expense.

• · The 2034 Notes are second-priority senior secured, guaranteed on a senior unsecured basis by Talos Energy Inc. and on a second-priority senior secured basis by subsidiary guarantors.
• · Interest on the 2034 Notes is payable semi-annually on January 15 and July 15, starting January 15, 2027.
• · The Issuer may redeem up to 40% of the original principal amount before July 15, 2029 at 108% of par using net equity offering proceeds within 180 days of closing.
• · After July 15, 2029, redemption prices step down: 104% in 2029, 102% in 2030, and 100% from 2031 onward.
• · The Indenture includes covenants limiting additional indebtedness, liens, dividends, investments, asset sales, affiliate transactions, and mergers.
• · Events of default include payment defaults, covenant breaches, failure of liens on collateral over $100M, cross-default on debt over $50M, and failure to pay judgments over $50M.
• · The Outside Date for the Gulf of America Acquisition under the Purchase Agreement is December 31, 2026.
• · The 9.000% Notes were redeemed in full on July 13, 2026 at 104.5% of principal plus accrued interest.

13-07-2026

GM Financial Consumer Automobile Receivables Trust 2026-3 filed an 8-K on July 13, 2026, announcing the issuance of approximately $1.01579 billion in asset-backed notes and a certificate, backed by prime automobile loan contracts. The transaction involves multiple classes of notes with varying interest rates and maturities, with the closing date set for July 15, 2026. The filing details the entry into material agreements including the underwriting, trust, indenture, sale and servicing, purchase, and asset representations review agreements.

• · The total principal amount of the Publicly Offered Notes is approximately $1.00012 billion (sum of Class A-1, A-2-A, A-2-B, A-3, A-4, and B).
• · The Class C Notes ($15,670,000) and the Certificate are not publicly offered.
• · The underlying assets are 'prime' automobile loan contracts secured by new and used automobiles, light duty trucks and utility vehicles.
• · The Issuing Entity was formed on June 3, 2026, with the Trust Agreement amended and restated as of July 15, 2026.
• · The Asset Representations Reviewer (Clayton) will perform reviews of certain Receivables for compliance with representations and warranties.
• · The Second Amended and Restated Servicing Agreement between AmeriCredit Financial Services, Inc. and General Motors Financial of Canada, Ltd. is dated January 1, 2006.

13-07-2026

Launch One Acquisition Corp. shareholders approved an amendment to extend the company's business combination deadline from 24 months post-IPO to January 15, 2027, at an extraordinary general meeting held on July 10, 2026. The amendment provides additional time to complete an acquisition, reflecting ongoing efforts to identify a target. No financial figures or performance metrics were disclosed in this filing.

• · The extraordinary general meeting was held on July 10, 2026 at 10:00am Eastern Time at Ellenoff Grossman & Schole LLP, New York.
• · The amendment changes the Completion Window definition to end on January 15, 2027, or earlier/later as approved by directors or members.
• · The original deadline was 24 months after the IPO closing date.

13-07-2026

Wrap Technologies launched WrapShield, an autonomous defense and public safety platform, beginning with a strategic investment in Frenel Imaging Ltd. that secures exclusive U.S. and NATO commercialization rights to TPiCore® thermal‑polarimetric sensing technology. The platform aims to connect detection, orchestration, and response for counter‑UAS and other security missions. No financial details of the investment or any comparative period data were disclosed in the filing.

• · WrapShield includes detection (TPiCore® thermal‑polarimetric sensing), orchestration (AI‑assisted, human‑supervised), and response (kinetic/non‑kinetic, lethal/non‑lethal).
• · Initial application is counter‑UAS; architecture designed to expand to defense, public safety, critical infrastructure, border security.
• · Frenel’s technology already in operational use in Israel.
• · WrapReality™ VR is a fully immersive training simulator for first responders.
• · WrapVision body‑worn camera includes cloud integration and a planned made‑in‑America roadmap for early 2026.
• · BolaWrap® is used by over 1,000 agencies in the U.S. and in 60 countries.

13-07-2026

Shutterstock announced that CEO Paul Hennessy has stepped down immediately, with CFO Rik Powell appointed as Interim CEO while continuing as CFO. The Board will engage a strategic advisor to formulate go-forward strategy and has commenced a search for a permanent CEO. Hennessy will remain in a non-executive advisory role through August 7, 2026. The filing does not provide any financial results or period-over-period comparisons, so no quantitative performance data is available.

• · Paul Hennessy served as CEO for 4 years and as a Board member for 11 years.
• · Rik Powell joined Shutterstock in June 2024 as SVP, Finance and Investor Relations, and became CFO in November 2024.
• · The Q2 2026 earnings call is scheduled for August 6, 2026 at 8:30am ET.
• · Hennessy will remain in a non-executive advisory capacity through August 7, 2026.

13-07-2026

Amesite Inc. held its 2026 Annual Meeting on July 13, 2026, where stockholders approved four proposals, including the election of two Class II directors (Ann Marie Sastry and Barbie Brewer), ratification of Novogradac & Company LLP as auditor, an amendment to the 2018 Equity Incentive Plan to increase shares by 1,000,000, and the issuance of shares upon exercise of Series A-1 and A-2 warrants. The meeting had a quorum of approximately 40% of outstanding shares (2,321,797 of 5,852,985 shares). While all proposals passed, the equity plan amendment received notable opposition (335,287 against vs. 1,148,268 for), indicating some shareholder dissent.

• · Proposal 3 (equity plan amendment) passed with 1,148,268 for, 335,287 against, and 9,686 abstentions – a significant 22.6% of votes cast against.
• · Proposal 4 (warrant share issuance) passed with 1,216,551 for, 130,855 against, and 145,835 abstentions.
• · Director Ann Marie Sastry received 1,287,736 for and 205,505 withheld; Barbie Brewer received 1,286,513 for and 206,728 withheld.
• · Auditor ratification passed with 2,091,129 for, 184,682 against, and 45,986 abstentions.
• · The company's address changed from Ann Arbor, MI to Detroit, MI (607 Shelby Street Suite 700 PMB 214).

13-07-2026

Sable Offshore Corp. (SOC) disclosed on July 10, 2026, that its independent auditor, Ham, Langston and Brezina, LLP (HL&B), resigned after CohnReznick LLP acquired certain HL&B assets. The Audit Committee approved the engagement of CohnReznick as the new auditor for fiscal year 2026. No disagreements or reportable events occurred with HL&B during the relevant periods, though HL&B's prior audit reports included a going-concern explanatory paragraph.

• · HL&B's audit reports for fiscal years 2023, 2024, and 2025 did not contain an adverse opinion or disclaimer, but included an explanatory paragraph about the company's ability to continue as a going concern.
• · No disagreements or reportable events occurred between the company and HL&B during the years ended December 31, 2025 and 2024, and the interim period through July 10, 2026.
• · The company did not consult with CohnReznick on any accounting, auditing, or financial reporting matters prior to engagement.

13-07-2026

Data I/O Corporation filed an 8-K on July 13, 2026, disclosing the adoption of the 2023 Omnibus Incentive Compensation Plan, which replaces the prior 2000 Stock Compensation Incentive Plan. The plan is designed to attract and retain employees, officers, consultants, and directors through stock-based awards, aligning their interests with shareholders. No financial figures or performance metrics were provided in this filing.

• · The plan is administered by the Compensation Committee of the Board, which must consist of independent directors under NASDAQ rules and non-employee directors under Rule 16b-3.
• · Awards under the plan include Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Stock Units, Dividend Equivalents, and Other Stock-Based Awards.
• · The plan includes a Change in Control definition with specific thresholds and exceptions, including a 50% voting power trigger and exclusions for certain financing transactions and domicile changes.
• · The plan replaces the prior 2000 Stock Compensation Incentive Plan.

13-07-2026

Edgewise Therapeutics completed the sale of sevasemten and its muscular dystrophy business to Servier for $1.55 billion in upfront cash and up to $1.1 billion in milestones, for total potential consideration of up to $2.65 billion. The transaction strengthens Edgewise's balance sheet and sharpens its focus on its cardiovascular pipeline, including EDG-7500 for hypertrophic cardiomyopathy, EDG-15400 for HFpEF, and EDG-003. The company expects to initiate a Phase 3 trial for EDG-7500 in Q4 2026 and a Phase 2 trial for EDG-15400 in HFpEF, with upfront proceeds expected to fully fund EDG-7500 through potential approval.

• · The GRAND CANYON pivotal cohort in Becker is fully enrolled with 175 participants and powered at >98% to show a statistically significant difference vs placebo, with top-line data expected in Q4 2026.
• · Sevasemten has FDA Orphan Drug Designation for Becker and Duchenne, Rare Pediatric Disease Designation for Duchenne, Fast Track designations for both, and EMA Orphan Drug Designations for both.
• · In the MESA open-label extension study, participants maintained stable NSAA scores over more than three years, contrasting with expected functional decline from natural history data.
• · Sevasemten has had no discontinuations or dose reductions due to adverse events.
• · Approximately 12,000 individuals are affected by Becker muscular dystrophy in the U.S., EU-5, and Japan.